FSA & HSA eligible
Affordable weight loss plans through Hers
Personalized weight loss plans with a range of treatment options, like oral medication kits starting at $69/mo1
Transparent, all-in pricing
No hidden fees
100% online, no in-person visit required
1. Pay upfront in full. Actual price to customer will depend on product and subscription plan purchase.
Oral medication kits are compounded drugs and have not been FDA-approved. FDA does not evaluate compounded drugs for safety, efficacy, or quality.
Ozempic® (semaglutide), Wegovy® (semaglutide), Mounjaro® (tirzepatide), and Zepbound® (tirzepatide), and Generic Liraglutide are not compounded. Ozempic®, Mounjaro®, and Generic Liraglutide are FDA-approved for type 2 diabetes treatment but may be prescribed off-label for weight loss at a healthcare provider's discretion. Wegovy® and Zepbound® are FDA-approved for weight loss. Ozempic® and Wegovy® are the registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. Hims, Inc. is not affiliated with or endorsed by Novo Nordisk A/S or Eli Lilly and Company.
Prescription products require an online consultation with a healthcare provider who will determine if a prescription is appropriate.
FSA/HSA eligibility and coverage varies by plan provider.